4 recalls found for Unichem Pharmaceuticals (USA), Inc.. Check if any of your products are affected.
Subpotent drug
Unichem Pharmaceuticals recalled Bisoprolol Fumarate and Hydrochlorothiazide tablets on January 21, 2026. The recall affects tablets that do not meet impurity specifications for N-Nitroso Bisoprolol. Consumers should stop using the product and contact their healthcare provider immediately.
Unichem Pharmaceuticals recalled 60,000 bottles of Doxazosin Tablets on January 21, 2026. The tablets were imprinted with the wrong ID, posing a serious risk to consumers. Healthcare providers and users should stop using the product immediately.
FDA enforcement lists 230 bottles of Cyclobenzaprine labeled incorrectly as Meloxicam. The labeling error was detected in a nationwide recall. Health professionals and patients should stop using the mislabeled bottles immediately. Contact Unichem Pharmaceuticals USA or a clinician for guidance.